Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04316169
Title Hydroxychloroquine, Abemaciclib and Endocrine Therapy in Hormone Receptor Positive (HR+)/Her 2 Negative Breast Cancer
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors Medical College of Wisconsin
Indications

Her2-receptor negative breast cancer

Advanced Solid Tumor

Therapies

Abemaciclib + Anastrozole + Hydroxychloroquine

Abemaciclib + Fulvestrant + Hydroxychloroquine

Abemaciclib + Hydroxychloroquine

Abemaciclib + Hydroxychloroquine + Letrozole

Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Froedtert Hospital and the Medical College of Wisconsin Recruiting Milwaukee Wisconsin 53226 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field